Fulvestrant Injection, Solution
Product Images NDC 70860-211

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fulvestrant (NDC 70860-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Athenex Pharmaceutical Division, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ful05 0005 01

Ful05 0005 01
FDA Label Image

Ful05 0005 02

Ful05 0005 02
FDA Label Image

Ful05 0005 03

Ful05 0005 03
FDA Label Image

Ful05 0005 04

Ful05 0005 04
FDA Label Image

Ful05 0005 05

Ful05 0005 05
FDA Label Image

Ful05 0005 06

Ful05 0005 06
FDA Label Image

Ful05 0005 07

Ful05 0005 07
FDA Label Image

Ful05 0005 08

Ful05 0005 08
FDA Label Image

Ful05 0005 09

Ful05 0005 09
FDA Label Image

Ful05 0005 10

Ful05 0005 10
The given text seems to be a graph representing the number of patients at risk, probability of Progression-Free Survival, and time of the course of treatment. It also has references to different drugs - fulvestrant, palbocicib, and placebo. The provided text may be useful for medical professionals in the cancer or breast cancer field to analyze probable outcomes based on the different treatments given.*
FDA Label Image

Ful05 0005 11

Ful05 0005 11
FDA Label Image

Ful05 0005 12

Ful05 0005 12
FDA Label Image

Ful05 0005 13

Ful05 0005 13
FDA Label Image

Ful05 0005 14

Ful05 0005 14
FDA Label Image

Ful05 0005 15

Ful05 0005 15
FDA Label Image

Ful05 0005 16

Ful05 0005 16

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.